Adam Hanina is CEO and co-founder of AiCure. He has been a strategist in healthcare software delivery for over fifteen years and holds over a dozen patents in his name. Prior to AiCure, he helped further develop Cerner Corporation\'s European strategy and was a Visiting Fellow of eHealth at Imperial College in London, UK. Mr. Hanina has spoken extensively on the topic of healthcare innovation and has acted as a subject-matter expert on medication adherence technologies for the National Institutes of Health (NIH). He is currently a principal investigator for multiple NIH innovation grants. He holds an MBA from the Wharton School of Business and an undergraduate degree from Brown University.
So, what happens if patients don't take the medications? It's a very simple problem. Well, in clinical research, clinical trials fail if they don't. And today, in most clinical trials in outpatient settings, it's not really known if patients are taking the experimental drug because they use blist...(Full transcript available to logged in subscribers.).
Register & Subscribe
Login
